Overview
Susumu Ohfuji practices practicing medicine in Sapporo, Japan.
His clinical expertise encompasses Mast Cell Activation Syndrome (MCAS) and Meningioma.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Susumu Ohfuji
Is Susumu Ohfuji a top-rated expert for Mast Cell Activation Syndrome (MCAS)?
MediFind is an objective health platform that identifies experts based on real-world data. Susumu Ohfuji is classified as an Experienced expert for Mast Cell Activation Syndrome (MCAS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Susumu Ohfuji participate in research or clinical trials?
Yes. Susumu Ohfuji has published 9 articles and abstracts on conditions like Mast Cell Activation Syndrome (MCAS). You can view a list of Susumu Ohfuji's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Mast Cell Activation Syndrome (MCAS)Mr. Ohfuji isExperienced. Learn about Mast Cell Activation Syndrome (MCAS).
- MeningiomaMr. Ohfuji isExperienced. Learn about Meningioma.